NCT00005056View on ClinicalTrials.gov

Bryostatin 1 In Treating Patients With Progressive Kidney Cancer

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

March 31, 1999

Study Completion Date

July 31, 2006

Conditions

Kidney Cancer

Interventions

DRUG

bryostatin 1

Trial Locations (2)

0X3 7LJ

Oxford Radcliffe Hospital, Oxford

OX3 7LJ

Imperial Cancer Research Fund Medical Oncology Unit, Oxford

Sponsors

Lead Sponsor

Cancer Research UK

All Listed Sponsors

lead

Cancer Research UK

OTHER